NEW YORK (TheStreet) -- Amazon (AMZN) - Get ReportApple (AAPL) - Get Report and Chipotle (CMG) - Get Report are just three stocks that almost every investor wants to own. But popularity like that comes with a hefty price tag, which makes it difficult for average investors to buy more than a handful of those shares.

Owning just 100 shares of Amazon, for instance, would cost you nearly $43,000, based on Friday's closing price. That's almost a bargain compared to the more than $51,000 it takes to buy 100 shares of Regeneron Pharmaceuticals  (REGN) - Get Report.

The good news is that there are plenty of exchange-traded funds with solid exposure to these pricey stocks. And they aren't expensive to own. So investors can use them to invest in the Amazons and Regenerons of the world without an excessive outlay of cash.

Consider the PowerShares Dynamic Biotechnology & Genome Portfolio (PBE) - Get Report, where eight of the top 10 stocks trade for over $100 per share.

That group includes names like  Biogen (BIIB) - Get Report and Cramer favorite Regeneron, PBE's largest holding at a weight of nearly 5.9%. The PowerShares Dynamic Biotechnology & Genome Portfolio, which is home to nearly $557 million in assets, is up 14.8% this year.

TheStreet Recommends

The ETF closed just under $58 Friday and its 52-week high is almost $59. Sticking with the theme of accessing high-priced stocks via ETFs, for the health care industry, the Market Vectors Pharmaceutical ETF (PPH) - Get Report also merits consideration.

The Market Vectors Pharmaceutical ETF holds just 26 stocks, but 10 of those holdings trade over $100. That group, which combines for over a third of the fund's weight, includes Novartis (NVS) - Get Report, Dow component Johnson & Johnson (JNJ) - Get Report, Valeant Pharmaceuticals (VRX) and McKesson (MCK) - Get Report. McKesson is a stock that Cramer says "never seems to go down."

As for PPH, the ETF is up almost 14% year-to-date and closed just over $73 last Friday.

In addition to biotechnology and pharmaceuticals, the online sector is another area rife with high-priced stocks, and the First Trust Dow Jones Internet Index Fund (FDN) - Get Report is an ideal way to gain exposure those names without shelling out big bucks. Its 10 largest holdings combine for 57% of the fund's weight, and that group includes Amazon, Netflix (NFLX) - Get Report and both classes of Google (GOOGL) - Get Report (GOOG) - Get Report as well as Priceline (PCLN) , which trades for more than $1,200 a share.

Throw in Equinix (EQIX) - Get Report and LinkedIn (LNKD) , and seven of FDN's top 12 holdings trade for well over $100, but the ETF itself resides under $68. It's up 10.7% year-to-date.

This article is commentary by an independent contributor. At the time of publication, the author owned shares of Johnson & Johnson.